K. Hauptmann

发表

Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry).

T. Heer, R. Schiele, S. Schneider, 2002, The American journal of cardiology.

Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.

H. Eggebrecht, H. Figulla, K. Hauptmann, 2011, European heart journal.

Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery.

K. Kuck, H. Mudra, K. Hauptmann, 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy

R. Schiele, M. Gottwik, U. Gieseler, 1999, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation.

G. Schuler, D. Holmes, K. Hauptmann, 2007, Journal of the American College of Cardiology.

Differences in patients with acute myocardial infarction treated with primary angioplasty or thrombolytic therapy

R. Schiele, M. Gottwik, U. Gieseler, 1999, Clinical cardiology.

Intravascular ultrasound comparison of the self‐expanding sideguard stent in the side branch versus a balloon‐expandable stent in the main vessel to assess mechanisms of acute lumen gain in bifurcation lesions

F. Prati, G. Mintz, G. Guagliumi, 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Endocarditis after transcatheter aortic valve implantation: a current assessment

K. Hauptmann, N. Kounis, I. Koniari, 2018, Journal of geriatric cardiology : JGC.

Restrictive perimembranous ventricular septal defect with left to right Shunt post urgent aortic balloon valvuloplasty and transcatheter aortic valve replacement

K. Hauptmann, N. Kounis, I. Koniari, 2018, Journal of geriatric cardiology : JGC.

Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006.

M. Hochadel, K. Hauptmann, J. Senges, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: results from the German Transcatheter Aortic Valve Interventions Registry.

K. Kuck, R. Erbel, H. Eggebrecht, 2012, American heart journal.

Mechanism of luminal patency of the self‐expanding sideguard sidebranch stent: Evaluation by intravascular ultrasound and optical coherence tomography

F. Prati, G. Mintz, G. Guagliumi, 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Primary angioplasty in acute myocardial infarction: differences between referred patients and those treated in hospitals with on-site facilities?

R. Schiele, M. Gottwik, T. Voigtländer, 1999, The Journal of invasive cardiology.

Angioplasty within 24 h after thrombolysis in patients with acute ST-elevation myocardial infarction: current use, predictors and outcome

A. Gitt, H. Wienbergen, K. Hauptmann, 2009, Clinical Research in Cardiology.

Reducing Patient Radiation Dose With Image Noise Reduction Technology in Transcatheter Aortic Valve Procedures.

K. Hauptmann, M. Lauterbach, 2016, The American journal of cardiology.

Giant right coronary artery aneurysm in an adult male patient with non-ST myocardial infarction.

K. Hauptmann, T. Gehrig, A. Halapas, 2013, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Differences in patients with acute myocardial infarction treated with primary angioplasty or thrombolytic therapy

R. Schiele, M. Gottwik, U. Gieseler, 1999, Clinical cardiology.

Primary percutaneous transluminal coronary angioplasty for acute myocardial infarction in patients not included in randomized studies. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.

R. Schiele, M. Gottwik, T. Voigtländer, 1999, The American journal of cardiology.

Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the ALKK-PCI registry

J. Brachmann, A. Gitt, K. Hauptmann, 2013, Clinical Research in Cardiology.

Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention

R. Virmani, S. Murphy, J. Popma, 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

In-hospital outcomes after elective and non-elective percutaneous coronary interventions in hospitals with and without on-site cardiac surgery backup

M. Hochadel, M. Gottwik, K. Hauptmann, 2009, Clinical Research in Cardiology.

Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis.

R. Fimmers, G. Nickenig, K. Hauptmann, 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.

N. Weissman, S. Nava, J. Fajadet, 2016, JACC. Cardiovascular interventions.

Coronary stenting with MGuard: extended follow-up of first human trial.

N. Uriel, K. Hauptmann, E. Kaluski, 2011, Cardiovascular revascularization medicine : including molecular interventions.

Coronary stenting with MGuard: first-in-man trial.

M. Klapholz, K. Hauptmann, E. Kaluski, 2008, The Journal of invasive cardiology.

Transcatheter Aortic Valve Implantation in the Hybrid Catheterisation Laboratory - Navigating into the Future

K. Hauptmann, M. Lauterbach, Bruno Sontag, 2012 .

High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.

S. Silber, C. Di Mario, A. Lansky, 2004, Journal of the American College of Cardiology.

Transcatheter valve‐in‐ring implantation of a repositionable valve system for treatment of severe mitral regurgitation

A. Paraforos, K. Hauptmann, I. Friedrich, 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

First-in-man (FIM) study of the Stentys bifurcation stent--30 days results.

P. Serruys, S. Ramcharitar, R. V. van Geuns, 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Five-year clinical outcome of multicenter randomized trial comparing amphilimus - with paclitaxel-eluting stents in de novo native coronary artery lesions.

K. Hauptmann, D. Carrié, A. Dibié, 2019, International journal of cardiology.

Randomized, double‐blind, multicenter study of the polymer‐based 17‐β estradiol‐eluting stent for treatment of native coronary artery lesions: Six‐month results of the ETHOS I trial

M. Leon, R. Mehran, A. Lansky, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Pre-clinical and Clinical Study Results for the Coracto ™ Rapamycin-eluting Stent - A New-generation Drug-eluting Stent

Saami K. Yazdani, Renu Virmani, Mariann Gyöngyösi, 2010 .

TCT-436 Multi-Center, Post-marketing Evaluation of the Elixir DESolve® Novolimus Eluting Bioresorbable Coronary Stent System: 6-month Results from the DESolve PMCF Study.

A. Colombo, K. Hauptmann, H. Nef, 2015, Journal of the American College of Cardiology.

Saphenous vein graft stenting using a novel filter device for distal protection.

K. Hauptmann, B. Chevalier, A. Seth, 2003, The American journal of cardiology.

The safety and efficacy of an extravascular, water‐soluble sealant for vascular closure: Initial clinical results for Mynx™

D. Scheinert, A. Schmidt, K. Hauptmann, 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Interventional treatment and outcome in elderly patients with stable coronary artery disease

J. Brachmann, H. Mudra, M. Hochadel, 2014, Herz.

Drug-eluting Stents Pre-clinical and Clinical Study Results for the Coracto ™ Rapamycin-eluting Stent – A New-generation Drug-eluting Stent

R. Virmani, S. Yazdani, F. Kolodgie, 2010 .

[Long-term follow-up of patients with acute myocardial infarction treated with primary angioplasty or thrombolysis. Results of the MITRA trial].

T. Heer, R. Schiele, S. Schneider, 2002, Zeitschrift fur Kardiologie.

Transcatheter Valve-in-Valve implantation after late migration of balloon expandable Sapien-XT prosthesis in a severe pure aortic regurgitation case

K. Hauptmann, N. Kounis, I. Koniari, 2017, Journal of geriatric cardiology : JGC.

7-Hexanoyltaxol–Eluting Stent for Prevention of Neointimal Growth: An Intravascular Ultrasound Analysis From the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE)

P. Fitzgerald, P. Yock, C. Di Mario, 2002, Circulation.

Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group.

R. Schiele, M. Gottwik, T. Voigtländer, 1999, American heart journal.

Monday, 27 August 2012

V. V. Ivanenko, E. A. Medvedeva, Michail I. Papafaklis, 2012 .

TAXUS I: Six- and Twelve-Month Results From a Randomized, Double-Blind Trial on a Slow-Release Paclitaxel-Eluting Stent for De Novo Coronary Lesions

Mary E. Russell, S. Silber, K. Hauptmann, 2003, Circulation.

Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9 eluting stent with a biodegradable polymer coating.

K. Hauptmann, A. Abizaid, L. Buellesfeld, 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study.

Patrick W Serruys, Giovanni Amoroso, Robert-Jan van Geuns, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for Coronary Artery Lesions

S. Silber, D. Dudek, A. Colombo, 2003, Circulation.

Volume–outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)

R. Dietz, T. Meinertz, M. Hochadel, 2007, Heart.

J. Brachmann, H. Mudra, M. Hochadel, 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Sideguard® dedicated stent system for the treatment of coronary bifurcation artery lesions

K. Hauptmann, A. Halapas, 2011 .

Glycoprotein IIb/IIIa antagonists during carotid artery stenting:

H. Mudra, M. Hochadel, K. Hauptmann, 2007, Clinical Research in Cardiology.

Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty

R. Schiele, M. Gottwik, T. Voigtländer, 1999, Heart.

Prospective multicenter evaluation of the direct flow medical transcatheter aortic valve.

Antonio Colombo, Neil Weissman, Francesco Maisano, 2014, Journal of the American College of Cardiology.

Facilitated Data Relay and Effects on Treatment of Severe Aortic Stenosis in Europe

C. Indolfi, B. Bouma, J. Rieber, 2019, Journal of the American Heart Association.

Symptoms, disease severity and treatment of adults with a new diagnosis of severe aortic stenosis

B. Bouma, J. Rieber, N. Frey, 2019, Heart.

Impact of coronary artery disease on in-hospital mortality in patients with aortic valve disease

G. Schuler, M. Hochadel, K. Hauptmann, 2013, Herz.

Embolic protection devices for carotid artery stenting: better results than stenting without protection?

N. Niedermaier, K. Hauptmann, J. Senges, 2004, European heart journal.

A multicenter randomized trial comparing amphilimus- with paclitaxel-eluting stents in de novo native coronary artery lesions.

K. Hauptmann, D. Carrié, A. Dibié, 2012, Journal of the American College of Cardiology.

Final 5-Year Results of the TAXUS II Trial: A Randomized Study to Assess the Effectiveness of Slow- and Moderate-Release Polymer-Based Paclitaxel-Eluting Stents for De Novo Coronary Artery Lesions

S. Silber, D. Baim, D. Dudek, 2009, Circulation.

Multicenter evaluation of a self-expanding carotid stent system with distal protection in the treatment of carotid stenosis.

G. Soulez, R. Beyar, M. Hill, 2006, AJNR. American journal of neuroradiology.

The NUGGET study: NIR ultra gold‐gilded equivalency trial

S. Silber, J. Webb, M. Morice, 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Fifteen-year experience with carotid artery stenting (from the carotid artery stenting-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte).

H. Mudra, M. Hochadel, K. Hauptmann, 2015, The American journal of cardiology.

Carotid artery stenting in clinical practice

M. Hochadel, K. Hauptmann, U. Zeymer, 2005, Zeitschrift für Kardiologie.

Determinants of mortality after cardiac surgery: results of the registry of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausärzte (ALKK) on 10 525 patients.

K. Hauptmann, U. Sechtem, U. Tebbe, 2000, European heart journal.

Randomized Comparison of the Nobori Biolimus A9-Eluting Coronary Stent With the Taxus Liberté Paclitaxel-Eluting Coronary Stent in Patients With Stenosis in Native Coronary Arteries: The NOBORI 1 Trial—Phase 2

P. Serruys, S. Silber, H. Suryapranata, 2009, Circulation. Cardiovascular interventions.

Age-stratified baseline and outcome characteristics of patients undergoing transcatheter aortic valve implantation: results from the German multicenter registry.

K. Kuck, R. Erbel, H. Figulla, 2012, The Journal of invasive cardiology.

Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I).

S. Silber, K. Hauptmann, M. Russell, 2005, The American journal of cardiology.

Carotid artery stenting: Do procedural complications relate to the side intervened upon?

H. Mudra, M. Hochadel, K. Hauptmann, 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Polymer-Free Biolimus A9-Coated Stents in the Treatment of De Novo Coronary Lesions: 4- and 12-Month Angiographic Follow-Up and Final 5-Year Clinical Outcomes of the Prospective, Multicenter BioFreedom FIM Clinical Trial.

G. Schuler, R. Mehran, H. Parise, 2016, JACC. Cardiovascular interventions.

Carotid artery stenting in octogenarians: results from the ALKK Carotid Artery Stent (CAS) Registry.

H. Mudra, M. Hochadel, K. Hauptmann, 2007, European heart journal.

Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)—registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)

J. Brachmann, H. Mudra, K. Hauptmann, 2010, Clinical Research in Cardiology.

Comparison of in-hospital outcomes of patients with versus without previous carotid endarterectomy undergoing carotid stenting (from the German ALKK CAS Registry).

M. Hochadel, R. Mehta, K. Hauptmann, 2007, The American journal of cardiology.

Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves (from the German TAVI Registry).

G. Nickenig, S. Schneider, K. Hauptmann, 2014, The American journal of cardiology.

A novel paclitaxel-eluting stent with an ultrathin abluminal biodegradable polymer 9-month outcomes with the JACTAX HD stent.

Georg Nickenig, N. Curzen, G. Nickenig, 2010, JACC. Cardiovascular interventions.

Incomplete Stent Apposition After Implantation of Paclitaxel-Eluting Stents or Bare Metal Stents: Insights From the Randomized TAXUS II Trial

P. Serruys, N. Bruining, D. Dudek, 2005, Circulation.

Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions.

P. Serruys, H. Garcia-Garcia, S. Ramcharitar, 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.

P. Fitzgerald, P. Serruys, K. Stangl, 2010 .

Clinical and angiographic analysis with a cobalt alloy coronary stent (driver) in stable and unstable angina pectoris.

K. Hauptmann, W. Rutsch, D. Glogar, 2006, The American journal of cardiology.

Effect of everolimus-eluting stents in different vessel sizes (from the pooled FUTURE I and II trials).

P. Fitzgerald, Y. Shimada, G. Dangas, 2006, The American journal of cardiology.

Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results.

P. Fitzgerald, K. Hauptmann, H. Sievert, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Randomised comparison of Nobori, biolimus A9-eluting coronary stent with a Taxus(R), paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.

P. Serruys, S. Silber, H. Suryapranata, 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

One year results of a new in situ length-adjustable stent platform with a biodegradable biolimus A9 eluting polymer: results of the CUSTOM-II trial.

P. Stella, M. Morice, J. Fajadet, 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study.

K. Kuck, L. Mauri, J. Fajadet, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Use of drug-eluting stents in acute myocardial infarction with persistent ST-segment elevation: results of the ALKK PCI-registry

M. Hochadel, K. Hauptmann, H. Darius, 2014, Clinical Research in Cardiology.

The role of echocardiography and CT angiography in transcatheter aortic valve implantation patients

K. Hauptmann, N. Kounis, I. Koniari, 2018, Journal of geriatric cardiology : JGC.

Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial.

K. Hauptmann, N. Reifart, D. Enayat, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A multicenter post‐marketing evaluation of the Elixir DESolve® Novolimus‐eluting bioresorbable coronary scaffold system: First results from the DESolve PMCF study

A. Colombo, K. Hauptmann, C. Hamm, 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

H. Mudra, M. Hochadel, K. Hauptmann, 2011, Clinical Research in Cardiology.

Carotid Artery Stenting in Clinical Practice: Does Sex Matter? Results From the Carotid Artery Stenting Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK)

H. Mudra, M. Hochadel, K. Hauptmann, 2012, Clinical cardiology.

TCT-46 Comparison of Polymer-Free BioFreedom™ Stents with Durable Polymer Taxus Liberté™ Stents: 3-Year Results from the BioFreedom First-In-Man Trial

G. Schuler, K. Hauptmann, J. Schofer, 2012 .

Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?

K. Hauptmann, J. Senges, U. Tebbe, 2005, Journal of the American College of Cardiology.

CORONARY ARTERY DISEASE Original Studies The Safety and Efficacy of an Extravascular, Water-Soluble Sealant for Vascular Closure: Initial Clinical Results for Mynx

D. Scheinert, A. Schmidt, K. Hauptmann, 2007 .

Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions.

M. Leon, A. Lansky, Ken Mori, 2006, The American journal of cardiology.

Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience).

H. Mudra, M. Hochadel, R. Mehta, 2009, The American journal of cardiology.

SCOREO trial interim safety results: despite efficacy, late stent thrombosis with the QuaDDS-QP2 stent

S. Silber, J. Fajadet, A. Colombo, 2002 .

K. Hauptmann, N. Reifart, D. Enayat, 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study.

P. Fitzgerald, P. Serruys, K. Stangl, 2010 .

SCORE six-month angiographic results: improved restenosis in patients receiving the QUADDS-QP2 drug-eluting stent compared with the control, bare stents

S. Silber, A. Lansky, J. Fajadet, 2002 .

Giant right coronary artery aneurysm in an adult male patient with non-ST myocardial infarction.

K. Hauptmann, T. Gehrig, A. Halapas, 2013, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

Embolic protection devices for carotid artery stenting: is there a difference between filter and distal occlusive devices?

K. Hauptmann, J. Senges, U. Tebbe, 2005, Journal of the American College of Cardiology.

Embolic protection devices for carotid artery stenting: better results than stenting without protection?

N. Niedermaier, K. Hauptmann, J. Senges, 2004, European heart journal.

STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: LONG-TERM RESULTS AFTER 6 YEARS OF THE WATCHMAN LEFT ATRIAL APPENDAGE OCCLUSION PILOT STUDY

G. Schuler, D. Holmes, K. Hauptmann, 2011 .